173 related articles for article (PubMed ID: 28293036)
1. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation.
Fukumoto A; Kim YP; Iwatsuki M; Hirose T; Sunazuka T; Hanaki H; Ōmura S; Shiomi K
J Antibiot (Tokyo); 2017 May; 70(5):568-573. PubMed ID: 28293036
[TBL] [Abstract][Full Text] [Related]
2. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Suzuki M; Onodera H; Tomoda H; Matsui H; Hanaki H; Iwatsuki M; Ōmura S; Shiomi K
J Antibiot (Tokyo); 2017 May; 70(5):562-567. PubMed ID: 28293038
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of (±)-naphthacemycin A
Hirose T; Kojima Y; Matsui H; Hanaki H; Iwatsuki M; Shiomi K; Ōmura S; Sunazuka T
J Antibiot (Tokyo); 2017 May; 70(5):574-581. PubMed ID: 27924114
[TBL] [Abstract][Full Text] [Related]
4. Aogacillins A and B produced by Simplicillium sp. FKI-5985: new circumventors of arbekacin resistance in MRSA.
Takata K; Iwatsuki M; Yamamoto T; Shirahata T; Nonaka K; Masuma R; Hayakawa Y; Hanaki H; Kobayashi Y; Petersson GA; Ōmura S; Shiomi K
Org Lett; 2013 Sep; 15(18):4678-81. PubMed ID: 24004199
[TBL] [Abstract][Full Text] [Related]
5. Paraphaeosphaeride D and berkleasmin F, new circumventors of arbekacin resistance in MRSA, produced by Paraphaeosphaeria sp. TR-022.
Suga T; Shiina M; Asami Y; Iwatsuki M; Yamamoto T; Nonaka K; Masuma R; Matsui H; Hanaki H; Iwamoto S; Onodera H; Shiomi K; Ōmura S
J Antibiot (Tokyo); 2016 Aug; 69(8):605-10. PubMed ID: 27328869
[TBL] [Abstract][Full Text] [Related]
6. The synergistic antibacterial activity of 1-acetyl-beta-carboline and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
Shin HJ; Lee HS; Lee DS
J Microbiol Biotechnol; 2010 Mar; 20(3):501-5. PubMed ID: 20372018
[TBL] [Abstract][Full Text] [Related]
7. Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics.
Roemer T; Schneider T; Pinho MG
Curr Opin Microbiol; 2013 Oct; 16(5):538-48. PubMed ID: 23895826
[TBL] [Abstract][Full Text] [Related]
8. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
[TBL] [Abstract][Full Text] [Related]
9. New streptophenazines from marine Streptomyces sp. 182SMLY.
Liang Y; Chen L; Ye X; Anjum K; Lian XY; Zhang Z
Nat Prod Res; 2017 Feb; 31(4):411-417. PubMed ID: 27097765
[TBL] [Abstract][Full Text] [Related]
10. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
[TBL] [Abstract][Full Text] [Related]
11. Zunyimycins B and C, New Chloroanthrabenzoxocinones Antibiotics against Methicillin-Resistant Staphylococcus aureus and Enterococci from Streptomyces sp. FJS31-2.
Lü Y; Shao M; Wang Y; Qian S; Wang M; Wang Y; Li X; Bao Y; Deng C; Yue C; Liu D; Liu N; Liu M; Huang Y; Chen Z; Hu Y
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208722
[TBL] [Abstract][Full Text] [Related]
12. Neopyrrolomycins with broad spectrum antibacterial activity.
Hopp DC; Rhea J; Jacobsen D; Romari K; Smith C; Rabenstein J; Irigoyen M; Clarke M; Francis L; Luche M; Carr GJ; Mocek U
J Nat Prod; 2009 Feb; 72(2):276-9. PubMed ID: 19191549
[TBL] [Abstract][Full Text] [Related]
13. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
[TBL] [Abstract][Full Text] [Related]
14. Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
Koyama N; Tokura Y; Takahashi Y; Tomoda H
Bioorg Med Chem Lett; 2013 Feb; 23(3):860-3. PubMed ID: 23265883
[TBL] [Abstract][Full Text] [Related]
15. Gold-Catalyzed Cyclization Leads to a Bridged Tetracyclic Indolenine that Represses β-Lactam Resistance.
Xu W; Wang W; Wang X
Angew Chem Int Ed Engl; 2015 Aug; 54(33):9546-9. PubMed ID: 26074499
[TBL] [Abstract][Full Text] [Related]
16. Two piperazic acid-containing cyclic hexapeptides from Streptomyces alboflavus 313.
Wei S; Fan L; Wu W; Ji Z
Amino Acids; 2012 Nov; 43(5):2191-8. PubMed ID: 22543750
[TBL] [Abstract][Full Text] [Related]
17. Subinhibitory fluoroquinolone exposure selects for reduced beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus and alterations in the SOS-mediated response.
Tattevin P; Basuino L; Chambers HF
Res Microbiol; 2009 Apr; 160(3):187-92. PubMed ID: 19366630
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of secondary metabolites isolated from Pestalotiopsis sp. FKR-0115 in overcoming β-lactam resistance in MRSA.
Taba K; Honsho M; Asami Y; Iwasaki H; Nonaka K; Watanabe Y; Iwatsuki M; Matsui H; Hanaki H; Teruya T; Ishii T
J Gen Appl Microbiol; 2024 Feb; 69(4):234-238. PubMed ID: 37302827
[TBL] [Abstract][Full Text] [Related]
19. Xanthoradones, new potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2 II. Structure elucidation.
Yamazaki H; Omura S; Tomoda H
J Antibiot (Tokyo); 2009 Aug; 62(8):435-7. PubMed ID: 19609292
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of chemical genetic interaction networks resensitize MRSA to β-lactam antibiotics.
Lee SH; Jarantow LW; Wang H; Sillaots S; Cheng H; Meredith TC; Thompson J; Roemer T
Chem Biol; 2011 Nov; 18(11):1379-89. PubMed ID: 22118672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
